An Investigation of Medial Temporal Lobe Changes and Cognition Following Antidepressant Response: A Prospective rTMS Study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND Major depressive disorder (MDD) is often resistant to treatment with standard approaches. Repetitive transcranial magnetic stimulation (rTMS) is a new treatment that has proven antidepressant efficacy in treatment resistant MDD (TRD). Preliminary evidence also raises the possibility of rTMS enhancing neuronal plasticity; with demonstrated increases in serum levels of brain derived neurotrophic factor (BDNF) found. This is of most relevance to volumetric reductions associated with MDD, particularly in the hippocampus and related structures. Extensive preclinical literature suggests that hippocampal volume reductions from MDD induced suppression of adult neurogenesis can be reversed by different types of classical antidepressant treatments which increase expression of BDNF. OBJECTIVE The aims of this study were to investigate whether antidepressant response to rTMS has similar therapeutic potential as antidepressant pharmacotherapy in promoting neurogenesis in the HC and surrounding structures and facilitating related neurocognitive improvements. METHODS Magnetic resonance imaging and neurocognitive assessments were conducted on 29 patients prior to rTMS treatment (baseline) and at three months post baseline (endpoint). RESULTS Over time, antidepressant response was associated with a near significant increase in left amygdala volume (6.58%), whilst treatment non-responders showed significant declines in left hippocampus volumes (-2.64%) from baseline. Functionally, there was no cognitive deterioration following rTMS treatment. The results are limited, however, by sample size. CONCLUSIONS These preliminary findings suggest that rTMS may promote neurogenesis or other effects that favour neuronal plasticity and may also be neuroprotective for patients with TRD but these findings need replication in a larger sample.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 8×
“Future studies focussing specifically on MTL structures in the pathophysiology of TRD are required to determine whether volumetric reductions function as a potential risk factor for treatment resistance or hold predictive value for favourable response to antidepressant treatment as with amygdala volumes.”
BackgroundInfluentialGeorge, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“[7,8] and several meta-analyses [9e12].”
Depression-Related Variation in Brain Morphology Over 3 Years: Effects of Stress?
Frodl, T. S., Koutsouleris, N., Bottlender, R., Born, C., Jäger, M., Scupin, I., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1156 · Cited by 359
Structural Brain Alterations following 5 Days of Intervention: Dynamic Aspects of Neuroplasticity
May, A., Hajak, G., Gänßbauer, S., Steffens, T., Langguth, B., Kleinjung, T., & Eichhammer, P. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhj138 · Cited by 344
Guse, B., Falkai, P., & Wobrock, T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0333-7 · Cited by 340 · cited 2×
“There is growing evidence in the literature to indicate that the effects of rTMS are widespread and not limited to the targeted cortical regions, as is indicated by the results of the current study [35,36,55,56].”
ResultPruessner, J. C., Dedovic, K., Pruessner, M., Lord, C., Buss, C., Collins, L., Dagher, A., & Lupien, S. J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.016 · Cited by 333
Gersner, R., Kravetz, E., Feil, J., Pell, G., & Zangen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6751-10.2011 · Cited by 313 · cited 2×
“There is growing evidence in the literature to indicate that the effects of rTMS are widespread and not limited to the targeted cortical regions, as is indicated by the results of the current study [35,36,55,56].”
BackgroundResultFrodl, T., Jäger, M., Smajstrlova, I., Born, C., Bottlender, R., Palladino, T., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0840 · Cited by 279
Hippocampal volume and 2-year outcome in depression
Kronmüller, K.-T., Pantel, J., Köhler, S., Victor, D., Giesel, F., Magnotta, V. A., Mundt, C., Essig, M., & Schröder, J. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.040378 · Cited by 107
Vanderhasselt, M.-A., de Raedt, R., Baeken, C., Leyman, L., & D'haenen, H. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701816514 · Cited by 40
Cognitive correlates of hypothalamic–pituitary–adrenal axis in major depression
Schlosser, N., Wolf, O. T., & Wingenfeld, K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.79 · Cited by 33 · cited 1×
“There is much inconsistency in the literature of amygdala volume as the structure has been shown to dynamically change throughout the course of illness, with enlarged volumes more prevalent in prodromal and first episode depressed patients and reduced volumes in progressed MDD illness [64].”
Background
Cited by
Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder
Fonseka, T. M., MacQueen, G. M., & Kennedy, S. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.049 · Cited by 185
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
“…depressive symptoms may promote chronic neuronal loss and suppress neurogenesis in the hippocampus (Boldrini et al., 2012, 2013; Duric et al., 2013; Furtado et al., 2013; Phillips et al., 2015), and preclinical work (Duman and Aghajanian, 2012; Licznerski and Duman, 2013; Bortolotto et al.,…”
BackgroundSerafini, G., Pompili, M., Belvederi Murri, M., Respino, M., Ghio, L., Girardi, P., Fitzgerald, P. B., & Amore, M. (2015) · Neuropsychobiology · doi:10.1159/000381351 · Cited by 101
Self-citationLan, M. J., Chhetry, B. T., Liston, C., Mann, J. J., & Dubin, M. (2016) · Brain Stimulation · doi:10.1016/j.brs.2016.02.011 · Cited by 96
Boes, A. D., Uitermarkt, B. D., Albazron, F. M., Lan, M. J., Liston, C., Pascual-Leone, A., Dubin, M. J., & Fox, M. D. (2018) · Brain Stimulation · doi:10.1016/j.brs.2018.01.029 · Cited by 94
“In addition we measured hippocampus volume to evaluate whether nonresponders had decreased hippocampus volume with rTMS treatment, as was reported previously [5] versus hippocampal enlargement, which has been reported recently in association with rTMS treatment for depression [6] and with some consistency with electro…”
Method
Metadata
- Authors
- Furtado, C. P., Hoy, K. E., Maller, J. J., Savage, G., Daskalakis, Z. J., & Fitzgerald, P. B.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 6
- Issue
- 3
- Pages
- 346-354
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W2014360838
- Cited by
- 67
- References
- 14
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.